期刊文献+

缬沙坦对单侧输尿管梗阻大鼠肾间质纤维化的影响 被引量:2

Effects of valsartan on renal interstitium fibrosis in rats after unilateral ureteral obstruction
下载PDF
导出
摘要 目的探讨血管紧张素ⅡⅠ型受体拮抗剂(AT1RA)缬沙坦对单侧输尿管梗阻(UUO)大鼠肾间质纤维化(RIF)的影响及其可能机制。方法35只SD大鼠随机分为假手术组、模型组和缬沙坦组(n=10),建立大鼠UUO模型,于术后4周检测血清肌酐(SCr)、血尿素氮(BUN)、血浆血管紧张素Ⅱ(AngⅡ),尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)、尿β2-微球蛋白(β2-MG);取梗阻侧肾组织,以H-E、Masson染色观察肾小管间质病变,免疫组织化学染色观察α-平滑肌肌动蛋白(α-SMA)、纤维连接蛋白(FN)、纤溶酶原激活物抑制剂1(PAI-1)、转化生长因子β1(TGF-β1)及肝细胞生长因子(HGF)在肾间质的阳性染色,并进行半定量分析。结果与假手术组相比,模型组大鼠SCr、BUN、血浆AngⅡ,尿NAG、β2-MG水平以及α-SMA、FN、PAI-1、TGF-β1表达均显著升高(P<0.01)。与模型组相比,缬沙坦组大鼠SCr、BUN,尿NAG及β2-MG水平差异无统计学意义(P>0.05),但血浆AngⅡ及肾间质α-SMA、FN、PAI-1、TGF-β1表达均显著降低,HGF表达则显著增高(P<0.01)。结论缬沙坦虽然对UUO大鼠肾小球、肾小管功能改善不明显,但能抑制AngⅡ的生成,可能通过下调TGF-β1的过度表达,上调HGF的表达,抑制α-SMA、FN、PAI-1的表达,从而抑制肾小管上皮细胞间充质转分化(EMT),减少细胞外基质(ECM)沉积,达到改善RIF的作用。 Objective To study the effect of valsartan,an angiotensinⅡtypeⅠreceptor antagonist(AT1RA),on renal interstitium fibrosis(RIF)in rats with unilateral ureteral obstruction(UUO),and to discuss the possible mechanisms.Methods Thirty-five Sprague-Dawley rats were randomly divided into sham-operation,model and valsartan groups.The rat UUO model was established.From the day after operation,the rats in sham-operation and model groups received intragastric valsartan and sodium chloride in tales doses.The serum creatinine(SCr),blood urea nitrogen(BUN),angiotensin-Ⅱ(AngⅡ) in blood plasma,N-acetyl-β-D-glucosaminidase(NAG)and 24 h urine β2-microglobulin(β2-MG)were examined 4 weeks after operation.The renal tissues of the obstructed sides were harvested;H-E staining and Masson staining were used to observe the tubulointerstitial lesions;and immunohistochemistry staining was used for semiquantitative analysis of alpha-smooth muscle actin(α-SMA),fibronectin(FN),plasminogen activator inhibitor-1(PAI-1),transforming growth factor-beta 1(TGF-β1),and hepatocyte growth factor(HGF).Results Compared with those in the sham-operation group,SCr,BUN,AngⅡ,NAG and β2-MG levels,and the expression of α-SMA,FN,PAI-1,and TGF-β1 in model group were significantly higher(P0.01).The levels of SCr,BUN,NAG and β2-MG were comparable between valsartan group and the model group(P〈0.05).The expression levels of α-SMA,FN,PAI-1,and TGF-β1 in valsartan group were significantly lower than and the expression of HGF was significantly higher than those in the model group(P0.01).Conclusion Valsartan does not improve the tubular and glomerular functions,but it can inhibit production of Ang-II.Valsartan may inhibit renal interstitial fibrosis by inhibiting renal tubule epithelial mesenchymal transdifferentiation and reducing extracellular matrix deposition through blocking up AngⅡ,inhibiting overexpression of α-SMA,FN,PAI-1,and TGF-β1,and inducing the HGF expression.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2010年第3期278-282,共5页 Academic Journal of Second Military Medical University
基金 上海市重点学科建设项目(Y0302)~~
关键词 单侧输尿管梗阻 肾间质纤维化 血管紧张素Ⅱ Α-平滑肌肌动蛋白 转化生长因子β 肝细胞生长因子 缬沙坦 模型组 大鼠 肾小管上皮细胞 unilateral ureteral obstruction renal interstitium fibrosis angiotensinⅡ alpha-smooth muscle actin transforming growth factor-beta 1 hepatocyte growth factor
  • 相关文献

参考文献12

  • 1李恒,唐政.肾脏固有细胞病理变化与慢性肾功能减退[J].肾脏病与透析肾移植杂志,2000,9(6):543-546. 被引量:9
  • 2王海燕.重视和研究小管-间质损害在肾小球疾病发展和预后中的作用[J].中华肾脏病杂志,2000,16(1):5-6. 被引量:85
  • 3Razzaque M S, Taguchi T. Cellular and molecular events leading to renal tubulointerstitial fibrosis[J].Med Electron Microse, 2002,35 : 68-80. 被引量:1
  • 4Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis[J]. Am J Pathol, 2001,159 : 1465-1475. 被引量:1
  • 5Yang J,Dai C, Liu Y. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction[J]. Am J Pathol, 2003,163 : 621-632. 被引量:1
  • 6Yang J, Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis[J]. J Am Soc Nephrol, 2002,13 : 96-107. 被引量:1
  • 7Kalluri R, Neilson E G. Epithelial mesenchymal transition and its implications for fibrosis[J]. J Clin Invest, 2003,112 : 1776-1784. 被引量:1
  • 8Neilson E G. Mechanisms of disease: fibroblasts--a new look at an old problem[J]. Nat Clin Pract Nephrol, 2006,2:101-108. 被引量:1
  • 9Yamaguchi I, Lopez-Guisa J M, Cai X, Collins S J, Okamura D M, Eddy A A. Endogenous urokinase lacks antifibrotie activity during progressive renal injury[J]. Am J Physiol Renal Physiol,2007,293:F12-F19. 被引量:1
  • 10高雯,狄佳,闻萍,江蕾,熊明霞,杨俊伟.血管紧张素Ⅱ参与肾小管上皮细胞转分化的实验研究[J].南京医科大学学报(自然科学版),2009,29(5):623-627. 被引量:1

二级参考文献35

  • 1Rastaldi MP. Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis[J]. J Nephrol,2006, 19(4):407-412. 被引量:1
  • 2Matsusaka T, Katori H, Miyazaki Y,et al. An giotensin Ⅱ as a player in fibrosis [J]. Nephrol Dial Transplant, 2000, 15(Suppl 6):64-65. 被引量:1
  • 3Ruiz-Ortega M, Ruperez M, Esteban V, et al. Angiotensin Ⅱ :a key factor in the inflammatory and fibrotic response in kidney diseases [J]. Nephrol Dial Transplant,2006,21 (1):16-20. 被引量:1
  • 4Song JH, Cha SH, Kim DH,et al. Dual blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin Ⅱ receptor blockers in chronic kidney disease [J]. J Hypertens Suppl,2006,24 (1) :S101-106. 被引量:1
  • 5Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention [J]. J Am Soc Nephrol, 2004,15(1) : 1-12. 被引量:1
  • 6Yang J,Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis [J]. J Am Soc Nephrol,2002,13 (1) :96-107. 被引量:1
  • 7Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis [J]. Am J Pathol,2001,159 (4) : 1465-1475. 被引量:1
  • 8Wynn TA. Cellular and molecular mechanisms of fibrosis [J]. J Pathol,2008,214(2) : 199-210. 被引量:1
  • 9Neilson EG. Mechanisms of disease:Fibroblasts--a new look at an old problem [J]. Nat Clin Pract Nephrol, 2006,2(2) : 101-108. 被引量:1
  • 10Roberts AB,Tian F,Flanders KC,et al. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis,tumor suppression and metastasis [J]. Cytokine Growth Factor Rev,2006,17(1-2) : 19-27. 被引量:1

共引文献97

同被引文献21

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部